January 14, 2015
Takeda Pharmaceutical’s US subsidiary will roll out an authorized generic (AG) version of its gout treatment Colcrys (colchicine) through Prasco Laboratories this week in a bid to counter a generic launch approved by US courts. The US unit will manufacture...read more